Synapse - Jakob Dupont

Results (65)

Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma

Journal Article

Leitao, M. M.; Soslow, R. A.; Nonaka, D.; Olshen, A. B.; Aghajanian, C.; Sabbatini, P.; Dupont, J.; Hensley, M.; Sonoda, Y.; Barakat, R. R.; more...
Cancer (2004)

Fulltext@MSK | Save

Use of soluble recombinant decoy receptor vascular endothelial growth factor trap (VEGF trap) to inhibit vascular endothelial growth factor activity

Journal Article

Konner, J.; Dupont, J.
Clinical Colorectal Cancer (2004)

Fulltext@MSK | Save

Phase II study of CT-2103 in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma

Journal Article

Sabbatini, P.; Aghajanian, C.; Dizon, D.; Anderson, S.; Dupont, J.; Brown, J. V.; Peters, W. A.; Jacobs, A.; Mehdi, A.; Rivkin, S.; more...
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Early detection and prognosis of ovarian cancer using serum YKL-40

Journal Article

Dupont, J.; Tanwar, M. K.; Thaler, H. T.; Fleisher, M.; Kauff, N.; Hensley, M. L.; Sabbatini, P.; Anderson, S.; Aghajanian, C.; Holland, E. C.; more...
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Phase I and pharmacokinetic study of the novel oral cell-cycle inhibitor Ro 31-7453 in patients with advanced solid tumors

Journal Article

Dupont, J.; Bienvenu, B.; Aghajanian, C.; Pezzulli, S.; Sabbatini, P.; Vongphrachanh, P.; Chang, C.; Perkell, C.; Ng, K.; Passe, S.; more...
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

KOS-862 (Epothilone D): Phase 1 dose escalating and pharmacokinetic (PK) study in patients (pts) with advanced malignancies

Meeting Abstract

Spriggs, D. R.; Dupont, J.; Pezzulli, S.; Larkin, J.; Cropp, G.; Zhou, Y.; Sherrill, M.; Johnson, R. Jr; Hannah, A. L.
EJC Supplements (2003)

Fulltext@MSK | Save

Phase 1 study of CT-2106 (polyglutamate camptothecin) in patients with advanced malingnancies

Meeting Abstract

Sayid, S.; Dupont, J.; McNamara, M.; Doroshow, J. H.; Pezzulli, S.; Spriggs, D.; Eastham, E.; Stromatt, S.; Takimoto, C.
Clinical Cancer Research (2003)

Fulltext@MSK | Save

WT1 expression in ovarian and endometrial carcinomas using tissue microarrays

Meeting Abstract

Wang, X.; Dupont, J.; Marshall, D. S.; Leitao, M.; Hummer, A.; Thaler, H.; Soslow, R. A.
Modern Pathology (2003)

Fulltext@MSK | Save

WT1 expression in ovarian and endometrial carcinomas using tissue microarrays

Meeting Abstract

Wang, X.; Dupont, J.; Marshall, D. S.; Leitao, M.; Hummer, A.; Thaler, H.; Soslow, R. A.
Laboratory Investigation (2003)

Fulltext@MSK | Save

Phase 1 dose escalating and pharmacokinetic (PK) study of KOS-862 (epothilone D): Phase 2 dose and schedule defined

Meeting Abstract

Spriggs, D.; Dupont, J.; Pezzulli, S.; Larkin, J.; Cropp, G.; Johnson, R.; Hannah, A. L.
Clinical Cancer Research (2003)

Fulltext@MSK | Save